Cronos Group Inc CRON shares are trading lower by 8.93% to $2.80 Monday morning after the company reported worse-than-expected third-quarter results.
What Happened?
Cronos Group reported quarterly losses of 10 cents per share which missed the analyst consensus estimate of a loss of 6 cents by 66.67 percent. The company also reported quarterly sales of $20.92 million which missed the analyst consensus estimate of $24.72 million by 15%. This is a 2.5% increase over sales of $20.41 million in the same period last year.
What Else?
"Market share gains through borderless innovation and cost rationalization were key drivers to this quarter's success," said Mike Gorenstein, Chairman, President and CEO, Cronos.
"While executing on our innovation pipeline, we also remain on track for the previously announced $20 to $25 million in operating expense savings for 2022," added Gorenstein.
According to data from Benzinga Pro, CRON has a 52-week high of $15.60 and a 52-week low of $8.42.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
